There are 2934 resources available
What is the current systemic approach in poor prognostic advanced melanomas?
Presenter: Paul Lorigan
Session: Special clinical scenarios in management of advanced melanoma
Resources:
Slides
4884 - Results of the ASCEND-7 phase II study evaluating ALK inhibitor (ALKi) ceritinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) metastatic to the brain
Presenter: Laura Chow
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
2693 - Integrated Genomic and DNA Methylation Analyses of Non-Small Cell Lung Cancer Patients with Brain Metastases
Presenter: Yanjun Xu
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
Proffered Paper – CNS tumours - Invited Discussant 392O, 393O and 394O
Presenter: Juan Sepulveda Sanchez
Session: Proffered Paper – CNS tumours
Resources:
Slides
Webcast
Proffered Paper 1 – Gynaecological cancers - Invited Discussant LBA58 and LBA59
Presenter: Antonio González Martín
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Slides
Webcast
Proffered Paper 1 – Gynaecological cancers - Invited Discussant LBA60 and 993O
Presenter: Domenica Lorusso
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Slides
Webcast
Biosimilars use in clinical practice: State of play
Presenter: Rosa Giuliani
Session: Biosimilars use in oncology: Clarifying concepts
Resources:
Slides
Webcast
Clarifying immunogenicity and switching for oncology biosimilars
Presenter: Pekka Kurki
Session: Biosimilars use in oncology: Clarifying concepts
Resources:
Slides
Webcast
Extrapolation of indications in oncology biosimilars
Presenter: João Gonçalves
Session: Biosimilars use in oncology: Clarifying concepts
Resources:
Slides
Webcast
Impact of biosimilars on the sustainability of healthcare systems
Presenter: Murray Aitken
Session: Biosimilars use in oncology: Clarifying concepts
Resources:
Slides
Webcast